Introduction
Excessive ethanol exposure is associated with an increased risk of a number of human cancers, including oral, pharyngeal, esophageal, hepatic, ovarian, colon, rectal, gastric, and breast and has also been suspected in pancreatic and lung cancers (Boffetta and 
Materials and Methods

Materials
Human plasma fibronectin was obtained from Chemicon International (Temecula, CA). Gentamicin sulfate was obtained from ICN Biomedicals, Inc. (Aurora, OH).
Sulfosuccinimidyl 2-(biotinamido) ethyl-dithioproprionate (sulfo-NHS-SS-biotin) and
NeutrAvidin agarose resin were purchased from Pierce (Rockford, IL (Luo et al. 1999) . For the treatment of jasplakinolide, HUVEC monolayers were pre-treated with 50 nM jasplakinolide for 4 hours and then jasplakinolide was removed by two washes using EGM-2 medium.
Transendothelial electrical resistance
Endothelial barrier function was measured by electrical resistance across HUVEC and BPAEC monolayers using Electrical Cell-Substrate Impedance Sensing 
MTT assay
The MTT assay was employed to determine the number of viable cells in culture.
Briefly, the cells were plated into 96-well plates and exposed to ethanol for indicated times. After the treatment, 10 µl of MTT reagent was added into each well and the plates were incubated at 37°C for 4 hours. The cultures were solubilized and spectrophotometric absorbance was measured at 595 nm using a microtiter plate reader (Beckman coulter). Toxicological Sciences   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60
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Immunofluorescence microscopy
The procedure for immunofluorescence microscopy has been previously described (Xu et al. 2007) . Briefly, cells were seeded on coverslips pre-coated with fibronectin (10 µg/ml). After treatment, cells were fixed with 3.7% paraformaldehyde for 10 min, washed 3 times in PBS, and permeabilized with 0.5% Triton X-100 for 5 min.
Cells were blocked with 5% BSA and incubated with primary antibodies for 1 hour.
Following incubation with primary antibodies, cells were washed and treated with Alexa
Fluor-labeled secondary antibodies, and rinsed with PBS. Coverslips were mounted with Prolong Gold anti-fade reagent, and images were captured using a Zeiss LSM 510 confocal microscope or an Olympus 1X81 inverted fluorescent microscope with the same exposure time, detector gain and amplifier offset.
Transendothelial migration (TEM) assay
The invasion of cancer cells through endothelial monolayers was measured with a TEM assay (Hordijk et al. 1999; Lee et al. 2003 
Immunoblotting and Immunoprecipitation
The procedure for immunoprecipitation and immunoblotting has been previously described (Ma et al. 2003; Xu et al. 2010a) . Briefly, cells were washed twice in ice-cold PBS, lysed in RIPA buffer (15 mM NaCl, 50 mM Tris, 1% NP-40, 0.5% sodium deoxycholate, 2 mM EGTA, 1 mM sodium vanadate, 1 mM phenylmethanesulfonyl fluoride, 5 µg/ml aprotinin and 2 µg/ml leupeptin). Samples were separated by centrifugation at 10,000 rpm for 10 min at 4°C. For immunoprecipitation, equal amounts of proteins (about 500-800 µg) were incubated with anti-VE-cadherin antibody overnight at 4°C, followed by treatment with Protein A/G Plus-agarose beads for 2 hours at 4°C.
Immunoprecipitates were collected by centrifugation at 10,000 g for 5 min at 4°C.
Samples were washed five times with RIPA buffer, one time with cold PBS and boiled in sample buffer (187.5 mM Tri-HCl, pH 6.8, 6% SDS, 30% glycerol, 150 mM DTT and 0.03% bromophenol blue). Proteins were resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes using a mini-Protean electrophoresis system. Protein blots were probed with indicated primary antibodies, followed by the appropriate horseradish peroxidaseconjugated secondary antibodies, and developed by enhanced chemiluminescence. 
Assessment of VE-cadherin distribution
VE-cadherin on the cell surface was quantified using a quantitative biotinylation assay (Le et al. 2002) . Briefly, a HUVEC monolayer was incubated at 0°C for 1 hour with 1 mg/ml sulfosuccinimidyl 2-(biotinamido) ethyl-dithioproprionate (sulfo-NHS-SSbiotin), a biotin-labeled cell impermeable reagent. Cells were washed once with a blocking reagent (50 mM NH4Cl in PBS containing 1 mM MgCl 2 and 0.1 mM CaCl 2 ) and then incubated at 0°C for 10 min to quench free sulfo-NHS-SS-biotin, followed by washes with cold PBS. Cells were lysed in RIPA buffer with protease inhibitors. Equal amounts of protein were incubated with NeutrAvidin agarose beads to collect biotinlabeled proteins, and then resolved by SDS-PAGE. VE-cadherin was identified using a rabbit polyclonal antibody directed against the extracellular domain of human VEcadherin, followed by a horseradish peroxidase-conjugated secondary antibody, and developed by enhanced chemiluminescence.
To evaluate intracellular VE-cadherin, trypsinization of VE-cadherin on the cell surface was performed (Gavard and Gutkind 2006) . Briefly, cells were incubated in trypsin-EDTA at 37 o C to cleave away the extracellular domain of VE-cadherin. Trypsin was inactivated by trypsin inhibitors. Cells were collected, centrifuged and pellets were lysed in RIPA buffer for immunoblotting analysis.
In trypsin-resistant fraction, internalized VE-cadherin was identified using a polyclonal antibody directed against the extracellular domain of VE-cadherin. 
Statistical analysis
Differences among treatment groups were tested using analysis of variance (ANOVA). Differences in which p was less than 0.05 were considered statistically significant. In cases where significant differences were detected, specific post-hoc comparisons between treatment groups were examined with Student-Newman-Keuls tests. 
Results
Ethanol disrupts endothelial integrity
We first tested the effects of ethanol on endothelial integrity in cultured HUVECs To determine whether the effect of ethanol was reversible, we removed the ethanolcontaining medium and replaced it with fresh medium. As shown in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 ethanol for 2 hours, VE-cadherin re-appeared in cell/cell junctions and cytoplasmic VEcadherin was reduced (Fig. 2C) . The data indicated that ethanol-induced disruption of the endothelial barrier was reversible. MTT assay confirmed that ethanol at the concentrations of 100 mg/dl or 200 mg/dl did not affect the viability of endothelial cells (Fig. 2D) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60
Ethanol increases cancer cell invasion through the endothelial monolayer
Ethanol induces the formation of actin stress fibers in endothelial cells
We have demonstrated above that ethanol disrupted the endothelial barrier and facilitated cancer cell invasion. We sought to investigate the underlying mechanism.
Dynamic organization of the actin cytoskeleton plays a critical role in endothelial integrity. Both in vivo and in vitro evidence supports that either depolymerization or hyper-polymerization of F-actin increases endothelial permeability (Waschke et al.
2005)
. In an untreated endothelial monolayer, peripheral actin, also called cortical actin,
was the predominant form of the actin cytoskeleton in HUVECs (Fig 4A) . Ethanol exposure rapidly induced the formation of actin stress fibers; the stress fibers were observed after 10 min of ethanol exposure and were accompanied by the appearance of intercellular gaps around the stress fibers. The ethanol-induced stress fiber formation was temporally correlated to the decrease in endothelial electrical resistance which is shown in Fig. 1 .
To determine whether ethanol-induced stress fiber formation was responsible for the alteration of endothelial integrity, we used jasplakinolide to stabilize actin filaments. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 the morphological results, jasplakinolide significantly attenuated an ethanol-induced decrease in endothelial electrical resistance (Fig. 4B) .
We next sought to determine whether stabilization of the actin cytoskeleton was sufficient to block ethanol-promoted invasion of cancer cells through the endothelial monolayer. As shown in Fig. 4C , pretreatment with jasplakinolide partially but significantly inhibited ethanol-stimulated invasion of cancer cells. Together, these data indicated that ethanol-induced actin stress fiber formation may be responsible for the disruption of the endothelial barrier, which facilitates cancer cell invasion. We examined the expression of adherens junctions and tight junctions in HUVECs.
Ethanol disrupts junctional VE-cadherin and induces endocytosis of VE-cadherin
Consistent with previous findings (Beese et al. 2010) , the expression of tight junctions in HUVEC cells was weak and adherens junctions were the predominant form of junction complexes (Fig. 5A) . Ethanol exposure induced a rapid loss of VE-cadherin in the intercellular junctions (Figs 1C and D) . Following prolonged exposure to ethanol (2 hours or more), the decrease in junctional VE-cadherin staining was accompanied by an accumulation of cytoplasmic VE-cadherin (Fig. 5B) , suggesting the endocytosis of VE- The unstable VE-cadherin/β-catenin complex may further increase endothelial permeability and subsequent cancer cell intravasation/extravasation.
Jasplakinolide antagonizes ethanol-induced loss of junctional VE-cadherin
The dynamics of actin cytoskeleton is important for the distribution and function of junctional VE-cadherin (Waschke et al. 2005) . We sought to determine whether ethanol-induced rearrangement of actin cytoskeleton mediated the dissociation of junctional VE-cadherin. In this experiment, HUVECs were pretreated with jasplakinolide for 4 hours to stabilize actin and then exposed to ethanol. As shown in Figure 7A , ethanol decreased junctional VE-cadherin and increased cytoplasmic VE-cadherin.
More importantly, jasplakinolide blocked the translocation of VE-cadherin and maintained cell surface VE-cadherin. This finding was confirmed by the experiment of VE-cadherin biotinylation. Jasplakinolide antagonized ethanol-induced loss of cell 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 surface VE-cadherin and attenuated the increase of trypsin-resistant intracellular VEcadherin (Figs. 7B to E). 
Ethanol-induced disruption of endothelial integrity
Disruption of the endothelial barrier has been reported to directly facilitate cancer disrupts the endothelial barrier, which is evident by a rapid decrease in electrical resistance of the endothelial monolayer, indicating an increased permeability (Fig. 1 ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 endothelial monolayer following ethanol exposure (Fig. 1) . The disruption of endothelial integrity occurs within 10 min and remains for at least 24 hours in the presence of ethanol. Ethanol (100-200 mg/dl) has little effect on cell viability and the disruption of endothelial integrity is reversible once ethanol is removed (Fig. 2) . More importantly, the disruption of endothelial integrity facilitates cancer cell invasion (Fig. 3) . The enhanced cancer cell invasion does not appear to be cell type-specific; the effect is 2010a). We cannot exclude the possibility that increased invasion across the endothelial monolayer results from enhanced aggressiveness of cancer cells. Our further study using jasplakinolide shows that maintaining endothelial integrity is sufficient to inhibit cancer cell invasion, indicating it is the increased permeability that facilitates cancer cell invasion. The study using jasplakinolide will be discussed in a greater detail later.
This is confirmed morphologically by the appearance of intercellular gaps in the
Actin stress fibers and endothelial integrity
Ethanol may disrupt endothelial integrity by numerous mechanisms and the change in the dynamics of the actin cytoskeleton is a potential one. We demonstrate that ethanol exposure decreases cortical actin and induces stress fiber formation ( 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 However, a high concentration of jasplakinolide (10 µM) increases the content of actin filaments and disrupts the integrity of the endothelial monolayer. We show that jasplakinolide at 50 nM inhibits ethanol-induced formation of stress fibers in endothelial cells and significantly attenuates ethanol-increased endothelial permeability (Fig. 4) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 inducing actomyosin contraction and focal adhesion formation (Hall 1998) . It is reported that ethanol promotes RhoA-mediated ROCK-1 activation in astrocytes (Minambres et al. 2006) . It remains to be investigated whether RhoA is involved in ethanol-induced rearrangement of actin filaments in endothelial cells. We demonstrate that ethanol decreases cell surface VE-cadherin, which is accompanied by an increase in intracellular VE-cadherin. Since ethanol does not affect total VE-cadherin, we conclude that ethanol causes VE-cadherin endocytosis. We note We demonstrate here that stabilization of actin filaments by jasplakinolide inhibits ethanol-induced VE-cadherin endocytosis (Fig. 7) , suggesting that ethanol-induced redistribution of VE-cadherin is initiated by its effect on the actin cytoskeleton.
Adherens junctions and endothelial integrity
Junctional VE-cadherin is associated with β-catenin, which is in turn linked to the actin cytoskeleton through α-catenin. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 24 hours and cell viability was determined with MTT assay as described under the Materials and Methods. The number of viable cells was presented relative to untreated controls. Each datum point was the mean ± SEM of three independent experiments. * denotes a statistically significant difference from untreated controls (p < 0.05). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 and biotin-labeled protein was precipitated as described under the Materials and
Methods. The expression of cell surface VE-cadherin was identified using a polyclonal antibody directed against the extracellular domain of human VE-cadherin. The expression of total VE-cadherin was also examined. D: HUVEC monolayer was exposed to ethanol (0 or 200 mg/dl) for indicated times and treated with trypsin-EGTA as described under the Materials and Methods. The cell lysates were collected and the internalized VE-cadherin (trypsin-resistant) was identified using a polyclonal antibody as described above. The expression of actin was used as a loading control. E and F: The relative expression of cell surface VE-cadherin (E) and intracellular VE-cadherin (F) was determined by densitometry and normalized to the total VE-cadherin (E) or actin (F),
respectively. * denotes a statistically significant difference from untreated controls (p < 0.05). These experiments were replicated three times. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 then exposed to ethanol (0 or 200 mg/dl) for 4 hours. VE-cadherin was visualized by immunofluorescence microscopy. Arrows indicate the cytoplasmic VE-cadherin. Scale bar = 10 µm. B and C: HUVEC monolayer was pretreated with Jasp (50 nM) for 4 hours and then exposed to ethanol (0 or 200 mg/dl) for 6 hours. The expression of cell surface VE-cadherin (B) and intracellular VE-cadherin (C) was determined as described in Fig. 5 . D and E: The relative expression of cell surface VE-cadherin (D) and intracellular VE-cadherin (E) was determined by densitometry and normalized to the total VE-cadherin (D) or actin (E), respectively. * denotes a statistically significant difference from untreated controls.
# denotes a significant difference from jasplakinolide-treated groups (p < 0.05). These experiments were replicated three times. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60 
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